Enanta Pharmaceuticals
ENTA
ENTA
107 hedge funds and large institutions have $391M invested in Enanta Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 52 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
5.25% more ownership
Funds ownership: 100.66% → 105.91% (+5.2%)
2% more funds holding
Funds holding: 105 → 107 (+2)
52% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 52
Holders
107
Holding in Top 10
2
Calls
$164K
Puts
$126K
Top Buyers
| 1 | +$16.6M | |
| 2 | +$15M | |
| 3 | +$10.1M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$8.8M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$6.78M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$6.4M | |
| 3 | -$5.25M | |
| 4 |
Goldman Sachs
New York
|
-$1.68M |
| 5 |
BlackRock
New York
|
-$1.67M |